Good app
Very Helpful.
Description
Cellular therapies can be associated with unique, acute toxicities which can be severe or even fatal if not identified early and treated appropriately.
Cytokine Release Syndrome (CRS), the most commonly observed toxicity can range in severity from low-grade constitutional symptoms to high-grade syndrome associated with life-threatening multi-organ disfunction. Neurotoxicity, originally termed CRES (CAR-Related Encephalopathy Syndrome) and now updated to ICANS (Immune effector Cell-Associated Neurotoxicity Syndrome) is the second most-common adverse even and can occur concurrently with CRS. A multi-disciplinary working group was formed to address safety issues for patients receiving cellular therapy which led to the development of new grading methods and treatment algorithms that have been incorporated into the CARTOX mobile app.
The CARTOX mobile app assists with grading toxicities, managing toxicities and assists with recommendations regarding appropriate antimicrobial prophylaxis for patients who have received immune effector cell therapy. Users are more easily able to determine if the patient is having cytokine release syndrome or neurotoxicity and to grade those toxicities.
Intended audience: Clinicians (physicians, nurse practitioners, physician assistants, pharmacists, nurses) who treat/care for patients receiving immune effector cells.
Hide
Show More...
Cytokine Release Syndrome (CRS), the most commonly observed toxicity can range in severity from low-grade constitutional symptoms to high-grade syndrome associated with life-threatening multi-organ disfunction. Neurotoxicity, originally termed CRES (CAR-Related Encephalopathy Syndrome) and now updated to ICANS (Immune effector Cell-Associated Neurotoxicity Syndrome) is the second most-common adverse even and can occur concurrently with CRS. A multi-disciplinary working group was formed to address safety issues for patients receiving cellular therapy which led to the development of new grading methods and treatment algorithms that have been incorporated into the CARTOX mobile app.
The CARTOX mobile app assists with grading toxicities, managing toxicities and assists with recommendations regarding appropriate antimicrobial prophylaxis for patients who have received immune effector cell therapy. Users are more easily able to determine if the patient is having cytokine release syndrome or neurotoxicity and to grade those toxicities.
Intended audience: Clinicians (physicians, nurse practitioners, physician assistants, pharmacists, nurses) who treat/care for patients receiving immune effector cells.
Screenshots
CARTOX FAQ
-
Is CARTOX free?
Yes, CARTOX is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is CARTOX legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does CARTOX cost?
CARTOX is free.
-
What is CARTOX revenue?
To get estimated revenue of CARTOX app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Russia yet.
Ratings History
CARTOX Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
418
|
CARTOX Installs
Last 30 days
CARTOX Revenue
Last 30 daysCARTOX Revenue and Downloads
Gain valuable insights into CARTOX performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- MD Anderson Cancer Center
- Languages
- English
- Recent release
- 2.5 (2 years ago )
- Released on
- Jun 2, 2019 (5 years ago )
- Also available in
- United States, Mexico, Spain, Pakistan, Italy, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Israel, Poland, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, Vietnam, South Africa, Denmark, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, India, Dominican Republic, Algeria, Ecuador, Egypt, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, United Arab Emirates
- Last Updated
- 3 days ago